These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2506020)

  • 1. Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.
    Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH
    Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):603-9. PubMed ID: 2506020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monocytogenes.
    Melissen PM; van Vianen W; Bidjai O; van Marion M; Bakker-Woudenberg IA
    Biotherapy; 1993; 6(2):113-24. PubMed ID: 8398570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
    Daemen T; Veninga A; Roerdink FH; Scherphof GL
    Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages.
    Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH; Michel MF
    Antimicrob Agents Chemother; 1986 Aug; 30(2):295-300. PubMed ID: 3094440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
    J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
    J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
    Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
    J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells.
    Sakita M; Kageyama N; Majima S
    Oncology; 1985; 42(4):259-64. PubMed ID: 4011111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I; Fidler IJ
    J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion pattern of the rat liver macrophage population following activation with liposomal muramyl dipeptide in vivo and in vitro.
    Hoedemakers RM; Morselt HW; Scherphof GL; Daemen T
    J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):265-72. PubMed ID: 8061899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE; Fidler IJ
    Int J Immunopharmacol; 1987; 9(2):141-50. PubMed ID: 3583507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres.
    Tabata Y; Ikada Y
    J Pharm Pharmacol; 1987 Sep; 39(9):698-704. PubMed ID: 2890735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
    Phillips NC; Rioux J; Tsao MS
    Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
    Daemen T; Veninga A; Dijkstra J; Scherphof G
    J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human alveolar macrophages: potentiation of their tumoricidal activity by liposome-encapsulated muramyl dipeptide.
    Sone S; Tsubura E
    J Immunol; 1982 Sep; 129(3):1313-7. PubMed ID: 7108208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice.
    Phillips NC; Tsao MS
    Cancer Immunol Immunother; 1991; 33(2):85-90. PubMed ID: 2036662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor cell binding and induction of endothelial cell tumoricidal activity in vitro by muramyl dipeptide is enhanced by liposomal encapsulation.
    Phillips NC; Stewart-Phillips J; Wang P
    J Immunother Emphasis Tumor Immunol; 1994 Apr; 15(3):185-93. PubMed ID: 8032541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent.
    Nagao S; Akagawa KS; Yamada K; Yagawa K; Tokunaga T; Kotani S
    Microbiol Immunol; 1990; 34(3):323-35. PubMed ID: 2352499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro.
    Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH
    Infection; 1988; 16 Suppl 2():S165-70. PubMed ID: 3138190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.